Binding of the chemokine CXCL12α to its natural extracellular matrix ligand heparan sulfate enables myoblast adhesion and facilitates cell motility

被引：0
|
作者：
Thakar, D. [3 ]
Dalonneau, F. [4 ]
Migliorini, E. [3 ]
Lortat-Jacob, H. [5 ]
Boturyn, D. [3 ]
Albiges-Rizo, C. [6 ]
Coche-Guerente, L. [3 ]
Picart, C. [4 ]
Richter, R. P. [1 ,2 ]
机构：
[1] Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Grenoble Alpes, CNRS, DCM, Grenoble, France
[4] Univ Grenoble Alpes, CNRS, Grenoble Inst Technol, LMGP, Grenoble, France
[5] Univ Grenoble Alpes, CNRS, IBS, CEA, Grenoble, France
[6] Univ Grenoble Alpes, INSERM, IAB, CNRS, Grenoble, France
来源：
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY | 2017年 / 98卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：A8 / A8
页数：1
相关论文
共 4 条
  • [1] Binding of the chemokine CXCL12α to its natural extracellular matrix ligand heparan sulfate enables myoblast adhesion and facilitates cell motility
    Thakar, Dhruv
    Dalonneau, Fabien
    Migliorini, Elisa
    Lortat-Jacob, Hugues
    Boturyn, Didier
    Albiges-Rizo, Corinne
    Coche-Guerente, Liliane
    Picart, Catherine
    Richter, Ralf P.
    BIOMATERIALS, 2017, 123 : 24 - 38
  • [2] Disaccharides generated from heparan sulfate or heparin modulate chemokine-induced T cell adhesion to extracellular matrix
    Hershkoviz, R
    Cahalon, L
    Mekori, YA
    Lider, O
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S107 - S107
  • [3] C3a primes B cell responses to SDF-1/CXCL12 by increasing its binding affinity to the CXCR4 chemokine receptor.
    Honczarenko, M
    Swierkowski, M
    Le, Y
    Glodek, AM
    Ratajczak, MZ
    Nicholson-Weller, A
    Silbertsein, LE
    BLOOD, 2003, 102 (11) : 823A - 823A
  • [4] CXC chemokine ligand 12 (CXCL12) via its cognate receptor (CXCR4) controls the chemotaxis of multiple myeloma cell line (U266) via PI3K/AKT, PLCβ3, RhoA, NFκB and ERK1/2
    Badr, Gamal
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 5 (22): : 2505 - 2512
1